PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-24.91%
Negative net income growth while MCHP stands at 255.08%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-9.09%
Both reduce yoy D&A, with MCHP at -2.13%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
1350.00%
Some yoy growth while MCHP is negative at -177.88%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-14.58%
Both cut yoy SBC, with MCHP at -1.77%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
62.22%
Slight usage while MCHP is negative at -180.39%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
248.05%
AR growth while MCHP is negative at -60.16%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
-200.00%
Negative yoy AP while MCHP is 64.81%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
8.75%
Some yoy usage while MCHP is negative at -123.08%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-195.65%
Negative yoy while MCHP is 19.20%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-11.95%
Both yoy CFO lines are negative, with MCHP at -16.22%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-9.40%
Both yoy lines negative, with MCHP at -46.35%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
9.40%
Acquisition growth of 9.40% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-109.94%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
38.64%
Below 50% of MCHP's 1250.00%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-5.41%
Both yoy lines negative, with MCHP at -47.12%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-110.18%
Both yoy lines negative, with MCHP at -38.85%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-75.26%
Negative yoy issuance while MCHP is 137.88%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-7.24%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.